Commodification of children again and non-disclosure preimplantation genetic diagnosis for Huntington’s disease
When is commodification acceptable? Preimplantation genetic diagnosis (PGD) is usually restricted to couples who are eligible for in vitro fertilisation (IVF)—infertile couples or those with a history of genetic disease. The Human Fertilisation and Embryology Authority (HFEA) in England and the Infe...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2004
|
In: |
Journal of medical ethics
Year: 2004, Volume: 30, Issue: 6, Pages: 538 |
Online Access: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
Summary: | When is commodification acceptable? Preimplantation genetic diagnosis (PGD) is usually restricted to couples who are eligible for in vitro fertilisation (IVF)—infertile couples or those with a history of genetic disease. The Human Fertilisation and Embryology Authority (HFEA) in England and the Infertility Treatment Authority (ITA) in Australia have both given permission for PGD with tissue typing to detect human leucocyte antigen (HLA) compatibility in order to save an existing sibling with a life threatening condition. The procedure has also been carried out in the United States.1 Heavy criticism followed the February 2002 ruling of England’s HFEA to allow a family to try for a child who is free of thalassaemia and a “perfect match” for a sick sibling.2 Then in August … |
---|---|
ISSN: | 1473-4257 |
Contains: | Enthalten in: Journal of medical ethics
|
Persistent identifiers: | DOI: 10.1136/jme.2002.002782 |